Methyldopa
Who holds supplier records for Methyldopa? 6 organisations hold a current record for Methyldopa: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4), Netherlands (1) and Hungary (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Methyldopa: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/methyldopa
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in China
4 of the 6 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Methyldopa. Country is the organisation's recorded country, not necessarily the manufacturing site.
- TAPI NL BVNetherlandsCEPActive DMF 26726 · latest filing Jan 2013
- Zhejiang Chiral Medicine Chemicals Co., Ltd.ChinaCEPActive DMF 20565 · latest filing May 2007
- Zhejiang Wild Wind Pharmaceutical Co.,Ltd.ChinaCEPActive DMF 22425 · latest filing Dec 2008
- ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTDChinaCEPActive DMF 42829 · latest filing Dec 2025
- ChinaCEP
- HungaryCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Methyldopa, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO., LTD. Chizhou City | CN | CEP 2025-297 - Rev 00 Methyldopa | Sept 2026 | — |
| ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. Taizhou | CN | CEP 2025-526 - Rev 00 Methyldopa, Site Yongtai Chiral, Process A | Jan 2026 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2010-326 - Rev 06 Methyldopa | Mar 2025 | — |
| ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. Hangzhou | CN | R1-CEP 2018-065 - Rev 00 Methyldopa, Process B | Jun 2023 | — |
| EGIS Pharmaceuticals PLC Budapest | HU | R1-CEP 1996-033 - Rev 07 Methyldopa | Apr 2019 | — |
| ZHEJIANG WILD WIND PHARMACEUTICAL CO., LTD. Geshan Town | CN | R1-CEP 2009-120 - Rev 01 Methyldopa | Apr 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Methyldopa are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- India · Inactive DMF 17699 · filed Sept 2004
- FARCHEMIA SRLInactive DMF 6140 · filed Dec 1985
- Italy · Inactive DMF 5725 · filed Dec 1984
- ACIC LTDInactive DMF 3472 · filed Feb 1979
- PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKSInactive DMF 3243 · filed Jun 1978
- Brazil · Inactive DMF 2696 · filed Jun 1976
Overview
Methyldopa is an antihypertensive medication primarily used to treat high blood pressure. It works by stimulating alpha-2 adrenergic receptors in the central nervous system, resulting in decreased sympathetic outflow, which leads to a reduction in blood pressure.
Chemical identity
- IUPAC name
- bis((2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid);trihydrate
- Canonical SMILES
- C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.O.O.O
- InChIKey
- YKFCISHFRZHKHY-NGQGLHOPSA-N
- Synonyms
- Aldomet API, aldomet, aldoril component methyldopa, alpha-methyldopa, dopamet, dopegyt, medopren, methyldopa hydrate, methyldopa sesquihydrate, methyldopum, mk-351, nsc-760080
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Central alpha-2 Adrenergic Agonist
- Mechanism of action
- Adrenergic alpha2-Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Methyldopa?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Methyldopa: TAPI NL BV (Netherlands), Zhejiang Chiral Medicine Chemicals Co., Ltd. (China), Zhejiang Wild Wind Pharmaceutical Co.,Ltd. (China), ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTD (China), ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO LTD (China) and Egis Pharmaceuticals PLC (Hungary). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Methyldopa Drug Master Files are active?
TAPI NL BV (DMF 26726), Zhejiang Chiral Medicine Chemicals Co., Ltd. (DMF 20565), Zhejiang Wild Wind Pharmaceutical Co.,Ltd. (DMF 22425) and ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTD (DMF 42829). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Methyldopa records mean?
6 organisations have only inactive Type II DMFs for Methyldopa. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Methyldopa have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Methyldopa on the EDQM register, including ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO., LTD. Chizhou City (CN), ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. Taizhou (CN), TAPI NL B.V. Amsterdam (NL), ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. Hangzhou (CN), EGIS Pharmaceuticals PLC Budapest (HU) and ZHEJIANG WILD WIND PHARMACEUTICAL CO., LTD. Geshan Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Methyldopa supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Methyldopa?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.